Introduction
The v-myb oncogene of avian myeloblastosis virus (AMV) encodes a transcription factor (referred to as vMyb) which is responsible for the ability of AMV to transform myelomonocytic cells in vivo and in vitro (for review see : Ness, 1996; Lipsick and Wang, 1999) . vMyb is an altered version of c-Myb, the protein encoded by the chicken c-myb gene. Nucleotide sequences from both ends of the c-myb coding region have been lost during retroviral transduction of the oncogene; in addition v-myb harbors several point mutations which result in a number of aminoacid replacements (Klempnauer et al., 1982 (Klempnauer et al., , 1983 . A large body of evidence indicates that c-myb is essential for the development of the hematopoietic system and plays an important role as a switch that directs hematopoietic progenitor cells to alternative fates, such as proliferation, dierentiation and apoptosis (Weston, 1998; Oh and Reddy, 1999) . c-myb is highly expressed in most hematopoietic progenitor cells and its expression is turned o during terminal dierentiation. Inhibition of c-myb reduces the proliferation potential of hematopoietic progenitor cells and induces apoptosis (Gewirtz and Calabretta, 1988; Taylor et al., 1996; Frampton et al., 1996; Weston, 1998) . By contrast, constitutive expression of c-myb arrests certain hematopoietic progenitor cells at an immature stage and prevents terminal dierentiation (reviewed in Weston, 1998; Oh and Reddy, 1999) . Mice lacking a functional c-myb gene die during embryonic development because of defects in fetal hepatic hematopoiesis (Mucenski et al., 1991) . c-myb is also expressed in certain nonhematopoietic cells and tissues (Desbiens et al., 1991; Queva et al., 1992; Plaza et al., 1995; Sitzmann et al., 1995; Rosenthal et al., 1996 , Ess et al., 1999 . Although it has been suggested that the role of c-myb in these cells is to prevent them from undergoing terminal dierentiation, the function of c-myb in non-hematopoietic cells is not well understood at present.
The proteins encoded by v-myb and c-myb bind to the sequence motif PyAAC G / T G (Biedenkapp et al., 1988) and activate promoters containing such binding sites (Klempnauer et al., 1989; Ness et al., 1989; Nishina et al., 1989; Weston and Bishop, 1989; Ibanez and Lipsick, 1990) . Mutation analysis of v-myb has shown that the transforming potential of the gene largely correlates with its ability to activate transcription of model reporter genes (Lane et al., 1990; Frampton et al., 1993) , suggesting that cell transformation by v-myb is caused by the activation of speci®c target genes. So far, only a few genes expressed in vmyb transformed myeloblasts have been identi®ed as targets of v-Myb, including mim-1 (Ness et al., 1989) , the lysozyme gene (Introna et al., 1990) , bcl-2 (Frampton et al., 1996; Taylor et al., 1996) , tom-1 , c-kit (Hogg et al., 1997) , GBX2 (Kowenz-Leutz et al., 1997), the adenosine receptor 2B gene and the CCAAT-box/ enhancer binding protein beta (C/EBPb) gene (Mink et al., 1999) . The activation of gene expression by v-Myb has been studied for some of these genes in detail. This work has led to the identi®cation of the members of the C/EBP family as important cooperation partners for v-Myb (Burk et al., 1993 Ness et al., 1993; Mink et al., 1996) . Cooperation between v-Myb and C/ EBP has been demonstrated primarily in the case of those v-Myb target genes whose expression is restricted to the myelomonocytic lineage. The promoters of several of these genes, including mim-1 and tom-1, contain both Myb and C/EBP binding sites juxtaposed to each other and have been found to be activated synergistically by both factors (Burk et al., 1993 Ness et al., 1993; Mink et al., 1996) . Despite this progress in the understanding of how v-Myb aects the expression of other genes, it has not yet been established whether or not any of the known Myb target genes plays a crucial role in the transformation of myelomonocytic cells by v-myb.
It is generally believed that only a small fraction of the genes whose expression is regulated by v-Myb have been identi®ed to date. We have used dierential display and a myelomonocytic chicken cell line that expresses an estrogen-inducible version of v-Myb to identify Myb-regulated genes (Burk and Klempnauer, 1991; Burk et al., 1997; . Here we describe the identi®cation of the chicken homolog of mouse Pdcd4 as a novel target gene of v-Myb.
Results

Identification of a novel v-Myb regulated gene by differential display
We have used 10.4 cells, a chicken macrophage cell line which has been stably transfected with an expression vector for an estrogen receptor/v-Myb fusion protein (Burk and Klempnauer, 1991) , to identify novel v-Myb regulated genes. Previous work has shown that treatment of the 10.4 cell-line with estrogen results in the activation of known v-Myb inducible genes, such as mim-1, tom-1, the lysozyme gene and others (Burk and Klempnauer, 1991; Burk et al., 1997; . 10.4 cells were cultivated for 24 h in the presence or absence of 2 mM b-estradiol and analysed by dierential display (Liang and Pardee, 1992) . A typical dierential display gel showing several dierentially ampli®ed cDNA fragments is depicted in Figure  1a . One of these fragments hybridized to a dierentially expressed mRNA of approximately 2.2 kb and was designated as i11/6. As illustrated in Figure 1b and c, the expression of i11/6 mRNA was induced by treatment of 10.4 cells with b-estradiol or with 4-hydroxytamoxifen ( Figure 1d ). i11/6 expression increased gradually over a period of 24 h after addition of b-estradiol (Figure 1e ), similar to other mybregulated genes (Burk and Klempnauer, 1991) .
We have shown before that estrogen treatment of 10.4 cells does not aect the amount of the Myb/ER fusion protein present in the cells but induces the activity of the protein (Burk and Klempnauer, 1991) . Estrogen-dependent conversion of the Myb/ER fusion protein from an inactive to an active form does not require de novo protein synthesis and, hence, can occur in the presence of a protein synthesis inhibitor (Burk and Klempnauer, 1991; Burk et al., 1997) . The Myb/ER system therefore is a very useful system to investigate whether or not the activation of a particular gene by v-Myb depends on protein synthesis and, thus, to distinguish genes regulated directly or indirectly by v-Myb. To determine whether the stimulation of i11/6 expression by v-Myb requires ongoing protein synthesis 10.4 cells were treated with b-estradiol in the presence or absence of 50 mg/ml cycloheximide followed by Northern blot analysis of i11/6 RNA expression. Control experiments have shown that this concentration of cycloheximide inhibits protein synthesis virtually completely (Burk et al., 1991) . As illustrated in Figure 2 , activation of i11/6 by v-Myb was observed under both conditions. We therefore concluded that v-Myb activates the i11/6 gene directly.
The i11/6 gene is activated by the v-Myb proteins of AMV and E26
The myb gene has been independently transduced by two avian retroviruses, AMV and E26, both of which transform myelomonocytic cells. The two versions of vmyb dier by a number of point mutations, some of which lead to aminoacid replacements in the v-Myb DNA-binding domain. As a result of these dierences the spectrum of target genes activated in AMV-and E26-transformed myelomonocytic cells is dierent. The expression of the mim-1 and lysozyme genes is elevated only in E26-transformed myeloblasts, whereas the tom-1 and adenosine receptor 2B genes are activated by both versions of v-Myb (Ness et al., 1989; Introna et al., 1990; Burk et al., 1997; . The GBX2 gene, by contrast, is expressed predominantly in AMV-transformed myeloid cells (KowenzLeutz et al., 1997) . To investigate whether activation of i11/6 is speci®c for a particular version of v-Myb, we analysed its expression in a panel of chicken cell lines, including AMV-and E26-transformed myeloblasts. As shown in Figure 3a , i11/6 mRNA was abundantly expressed in AMV-transformed myeloblasts and, at somewhat lower levels, also in the E26-transformed cell line, suggesting that both viruses activate the gene.
We also analysed the i11/6 expression in subclones of the HD11 cell line that have been stably transfected with expression vectors for the AMV or E26 versions of v-Myb, or with a control vector ( Figure 3b ). Northern blot analysis of these clones showed that expression of the i11/6 transcript was induced by both versions of v-Myb. The expression of i11/6 mRNA in these cell lines also demonstrates that the activation of the gene is not an artifact of the v-Myb/ER system.
To con®rm that both v-myb containing viruses induce i11/6 expression we performed Northern blot analyses of primary E26 or AMV-transformed chicken myeloblasts, which were kindly provided by T Graf. As shown in Figure 3c , substantial levels of i11/6 mRNA were present in cells transformed by both viruses. The expression of the gene was higher in AMV-than in E26-transformed cells, suggesting that in primary transformed cells the i11/6 gene shows a preference for activation by AMV v-Myb. This is also suggested by the analysis of the dierent cell lines shown in Figure 3a . E26-transformed multipotent progenitor cell lines HD50 and HD57 also express the i11/6 gene, although the levels of expression are much lower than in E26-transformed myeloblasts ( Figure 3d ).
Besides v-myb transformed myeloblasts, many other cell lines also express substantial levels of i11/6 mRNA.
The spectrum of cell lines shown in Figure 3a includes myelomonocytic cells lacking either v-Myb or c-Myb (HD11), erythroid cells (HD3), B-and T-lymphoid cells (SC2L and MSB1, respectively) as well as nonhematopoietic cells (CEF). It is therefore evident that i11/6 is not activated exclusively by Myb.
We also analysed the expression of the i11/6 gene in a number of adult chicken tissues (Figure 3e ). The highest levels of i11/6 mRNA were detected in hematopoietic organs, such as thymus and bursa, whereas somewhat lower levels were detected in the kidney. Other tissues showed weak or undetectable expression of the gene.
The i11/6 gene is highly homologous to the Pdcd4/MA-3 gene
We determined the nucleotide sequence of the i11/6 dierential display fragment (not shown) and found that it had no homology to known genes, suggesting that i11/6 is a novel myb-inducible gene. To isolate a full-length i11/6 cDNA clone, we screened a cDNA library of AMV-transformed myeloblasts using the dierential display fragment as a probe. Nucleotide sequencing of the resulting clones revealed a long open reading frame potentially encoding a 467 amino acid protein with a calculated molecular weight of approximately 52 000 (Figure 4 ). The deduced protein has a high content of hydrophilic aminoacids and does not contain any obvious structural motifs. Comparison of the aminoacid sequence of the putative i11/6 protein with that of other known proteins revealed a high degree of homology (85% aminoacid identity) to the proteins encoded by the mouse MA-3 gene and the human H731-like gene. The MA-3 gene has originally been isolated in a search for genes activated in cells undergoing apoptosis (Shibahara et al., 1995) . The function of MA-3 is unknown, however its expression is elevated upon induction of apoptosis in a variety of cell systems (Shibahara et al., 1995) . The MA-3 gene has also been designated as Pdcd4 and was cloned independently in a study designed to identify genes which are dierentially expressed between two subclones of a mouse cell line that dier in their ability to undergo tumor-promotor induced neoplastic transformation (Cmarik et al., 1999) . Pdcd4/MA-3 has also been isolated in a search for genes whose expression is repressed by topoisomerase inhibitors ± in this study the gene was named TIS (Onishi and Kizaki, 1996) . A human homolog of mouse Pdcd4/MA-3/TIS has been cloned as the gene encoding the antigen recognized by the monoclonal antibody H731 and designated as the H731-like or a shorter cDNA version as H731 gene (Matsuhashi et al., 1997) . In addition to the mouse and human genes less well conserved homologs of i11/6 exist in the fruit-¯y Drosophila melanogaster (referred to as CG10990; Accession number AAF48312) and in the marine sponge Suberites domuncula (Wagner et al., 1998) . This indicates that the i11/6 gene has been very highly conserved during evolution. Stimulation of i11/6 expression in the presence of cycloheximide. 10.4 cells were grown in the presence (+ cyc) or absence (7 cyc) of 50 mg/ml cycloheximide either with (+) or without (7) 2 mM b-estradiol. The hormone was added to the cultures 15 min later than cycloheximide. Cells were harvested 5 h after addition of hormone. Polyadenylated RNA was analysed by Northern blotting using the i11/6 dierential display fragment as probe (top)
Expression of the chicken i11/6 gene is not altered in cells undergoing UV-or AraC-induced apoptosis As mentioned above, mouse MA-3 (alias Pdcd4) was originally isolated in a search for genes whose expression was upregulated during apoptosis in several model systems (Shibahara et al., 1995) . The observation that MA-3 expression is increased during apoptosis induced by a range of stimuli in several dierent cell systems has suggested that activation of MA-3 expression might be a general feature of apoptotic cells. We were therefore interested to determine whether the expression of the i11/6 gene was also increased during apoptosis in chicken cells. To address this question we turned to the chicken B-cell line DT40 which has been used before as a model system for the induction of apoptosis in chicken cells (Lahti, 1999; Qin et al., 1997; Maruo et al., 1999) . As shown in Figure 5a and b, DT40 cells underwent apoptosis after UV-irradiation or exposure to Ara-C, as evidenced by the appearance of nucleosomal DNA fragments. However, in contrast to the observed upregulation of the mouse MA-3 gene during apoptosis (Shibahara et al., 1995) , the amount of i11/6 mRNA did not increase during apoptosis under these conditions.
Subcellular localization of the i11/6 protein
The molecular function of i11/6 or its homologs is presently unknown. To begin to study the function of the i11/6 gene we generated an expression vector encoding a HA-tagged version of the full-length i11/6 protein and determined its subcellular localization. QT6 ®broblasts were transfected with this expression vector and subsequently analysed by Western blotting 3), pVM134 (E26 v-Myb; clones 27.5 and 27.10) or pVM111 (control vector; clones 28.3 and 28.4) was hybridized to i11/6-speci®c and GAPDH-speci®c probes. (c) Total RNA from primary myeloblasts transformed by AMV (AMV tr.) was analysed by Northern blotting using the i11/6-speci®c (top) and GAPDH-speci®c probes (bottom). (d) Total RNA from E26 virus transformed myeloblasts (E26 tr.) and the E26-transformed MEP cell-lines HD50 and HD57 was hybridized to i11/6-speci®c (top) or GAPDH-speci®c probes (bottom). (e) Total RNA from the indicated tissues of a 4-week-old chicken was analysed by Northern blotting using i11/6-speci®c (top) and GAPDH-speci®c probes (bottom) using HA-speci®c antibodies. As shown in Figure 6a an approximately 60 kD protein was detected in total cell extracts of cells transfected with the HA-i11/6 expression vector but not in extracts prepared from control cells. We noted that the apparent molecular weight of Figure 4 The i11/6 gene is homologous to the mouse Pcdc4/ MA-3 gene. Amino acid sequence comparison of the deduced chicken i11/6 protein (top), the human H731-like protein (middle) and the mouse MA-3 protein (bottom). Dierences in aminoacid sequence between the chicken and the mouse or human protein are marked by boxes Figure 5 i11/6 expression during UV-and Ara-C-induced apoptosis. Apoptosis was induced in DT40 cells by UVirradiation (a) or by treatment with 10 mM Ara-C (b). Cells were harvested before treatment or after 1, 2, 4 or 8 h. Total RNA prepared from these cells was hybridized to i11/6-speci®c (top) or GAPDH-speci®c probes (middle). In addition, total cellular DNA isolated from separate aliquots of the cells was analysed by agarose gel electrophoresis (bottom) Figure 6 Subcellular localization of the i11/6 protein. (a) QT6 cells were transfected with an expression vector for HA-tagged full-length i11/6 protein (i11/6HA) or with the empty expression vector (pcDNA3). Twenty-four hours after transfection total cell extracts were fractionated by 10% SDS ± PAGE and analysed by Western blot analysis using a HA-speci®c monoclonal antibody. The sizes (in kilodaltons) and positions of molecular weight markers are shown on the left side. (b ± e) QT6 cells were transfected as in a. Twenty-four hours after transfection cells were analysed by immuno¯uorescence microscopy using a HA-speci®c monoclonal antibody. (b,c) Cells transfected with HA-i11/6 expression vector; (d,e) cells transfected with empty expression vector; (b,d) immuno¯uorescent staining; (c,e) phase contrast the HA-tagged i11/6 protein was slightly higher than the molecular weight calculated from its aminoacid sequence, suggesting that the protein migrates aberrantly during SDS-polyacrylamide gel electrophoresis or that it is modi®ed posttranslationally. To determine the subcellular localization of the protein, we performed immuno¯uorescence staining experiments using cells transiently transfected with the i11/6 expression vector. As shown in Figure 6b , there was a clear nuclear¯uorescence in the i11/6-transfected cell population that was not detected in the control cells. We also noted a weak cytoplasmic staining in the transfected cells. Thus, it appears that the i11/6 protein resides predominantly in the nucleus.
Discussion
There is strong evidence that the transformation of myelomonocytic cells by v-Myb is due to the activation of speci®c target genes whose deregulated expression is thought to interfere with the normal dierentiation program of these cells. In order to understand how vMyb transforms myeloid cells it is therefore crucial to identify the genes whose expression is aected by vMyb. We have used a myelomonocytic chicken cell line that harbors a v-Myb/estrogen receptor fusion protein to search for genes whose expression is upregulated by v-Myb. Analysis of this cell line by dierential display has already led to the identi®cation of two mybregulated genes, tom-1 and the adenosine receptor 2B gene . Here, we describe the identi®cation of a novel v-Myb target gene, initially designated as i11/6. Several lines of evidence indicate that i11/6 is a bona ®de mybregulated gene. Expression of i11/6 is increased upon treatment of the v-Myb/ER expressing cell line with estrogen or hydroxytamoxifen. Stable transfectants of the chicken macrophage HD11 cell line expressing the AMV or E26 version of v-Myb show elevated expression of the gene. Furthermore, primary AMVand E26-transformed myeloblasts also express high levels of i11/6 mRNA, argueing against the possibility that the expression of the gene is somehow arti®cially stimulated by the v-Myb/estrogen receptor fusion protein. We have also shown that expression of the i11/6 gene is induced by estrogen even in the presence of the protein synthesis inhibitor cycloheximide, strongly suggesting that the i11/6 gene is a direct target of v-Myb. Recently, we have cloned the promoter region of the i11/6 gene; we have found that the i11/6 promoter contains Myb binding sites and is activated by Myb in reporter gene assays (unpublished observations). Together with the evidence presented here these observations strongly suggest that the i11/6 gene is a bona ®de myb target gene.
Comparison of the aminoacid sequence of the deduced i11/6 protein with that of other known proteins shows that the i11/6 gene is very similar to the mouse Pdcd4 and the human H731 gene. In addition, more distant homologs of i11/6 can be detected in the genomes of the marine sponge Suberites domuncula and the fruit-¯y Drosophila melanogaster. Thus, the i11/6 gene has been very highly conserved during evolution. Because of the high degree of homology, and the fact that hybridization of a mouse MA-3 probe to chicken genomic DNA yielded only one labeled DNA fragment (Shibahara et al., 1995) , we think that the gene we have isolated is the chicken homolog of mouse Pdcd4 (MA-3/TIS) and human H731. Therefore, we will refer to the novel gene described here as chicken Pdcd4.
Chicken Pdcd4 is expressed preferentially in hematopoietic cell lines and tissues, such as thymus and bursa. In the hematopoietic system the expression of Pdcd4, unlike that of several of the known v-Myb target genes, is not limited to cells of myelomonocytic lineage but extends to other hematopoietic lineages as well. Pdcd4 is also expressed in E26-transformed multipotent hematopoietic progenitor cells, although not as highly as in cells committed to the myleomonocytic lineage. Taken together, these observations, as well as the conservation of the gene among very divergent eucaryotic species, suggest that Pdcd4 performs an important function in a broad spectrum of hematopoietic cell types. It is clear, however, that the gene is also expressed in nonhematopoietic cells and that factors other than Myb contribute to its expression.
The function of Pdcd4 is presently unknown. The mouse Pdcd4 gene (alias MA-3) has originally been isolated in a search for genes activated in cells undergoing apoptosis (Shibahara et al., 1995) . The observation that the expression of the gene is upregulated during apoptosis in a variety of murine cell systems has suggested that an increase in Pdcd4/ MA-3 expression might be a general marker of apoptotic cells and that the gene might play an important role in programmed cell death (Shibahara et al., 1995) . However, no causal relationship to apoptosis has been established. For example, ectopic expression of MA-3 did not trigger apoptosis or increase the sensitivity of the cells for induction of apoptosis (Shibahara et al., 1995) . Our own studies, using UV-irradation and treatment with Ara-C as potent inducers of apoptosis in the DT40 B-cell line, have failed to show upregulation of Pdcd4 in chicken cells undergoing programmed cell death. Thus, in the chicken system there is presently no evidence that apoptosis is associated with increased expression of the Pdcd4 gene. We cannot, of course, exclude the possibility that the Pdcd4 gene is activated during apoptosis in other chicken cell types or after using dierent stimuli to trigger apoptosis. However, it is clear that there is not a strict correlation of Pdcd4 expression and apoptosis in chicken cells. Recent studies in murine cells have led to the cloning of Pdcd4 as a gene whose expression is suppressed by topoisomerase inhibitors (Onishi and Kizaki, 1996; Onishi et al., 1998) . In these studies Pdcd4 was referred to as TIS. Topoisomerase inhibitors are also known to induce apoptosis; the observation that TIS expression is decreased by topoisomerase inhibitors also argues against the idea that increased Pdcd4/MA-3 expression is a general feature of apoptotic cells.
The most interesting observations regarding the possible function of the Pdcd4 gene are derived from recent studies of two subclones of a murine cell line, diering in their ability to undergo tumor promotor induced neoplastic transformation (Cmarik et al., 1999) . In these studies it was shown that Pdcd4 is highly expressed in a tumor promoter resistant clone of the mouse epidermal cell line JB6 but not in a tumor promoter sensitive subclone of the same cell line. Downregulation of Pdcd4 expression in the tumor promoter resistant subclone, caused by expression of a Pdcd4 antisense construct, converted the phenotype of the cells such that they became sensitive to the tumor promoter. Moreover, re-expression of Pdcd4 in the antisense treated cells again restored the tumor promoter resistant phenotype. Thus, in this model system of tumor development the Pdcd4 gene is intimately involved in controlling the ability to undergo neoplastic transformation. The observation that Pdcd4 expression inhibits cell transformation raises the interesting possibility that the Pdcd4 gene is a tumor suppressor gene. It will therefore be very interesting to examine tumor cells for alterations aecting the the expression or the structure of the Pdcd4 gene, particularly in the hematopoietic system, where the gene is preferentially expressed.
At present we do not understand the role of Pdcd4 in the v-myb induced transformation of myeloid cells. The ®ndings that Pdcd4 is able to suppress tumor promotor mediated transformation of epidermal cells and that the Pdcd4 protein is located predominantly in the nucleus, suggest that the protein may somehow regulate signal transduction pathways such as the ones triggered by tumor promoters, possibly by directly modulating gene expression. It is somewhat surprising that an oncogene such as v-myb induces the expression of a potential tumor suppressor gene. However, at present we do not know whether Pdcd4 is directly involved in v-myb-dependent transformation of myeloid cells or whether the function of the gene diers between hematopoietic and non-hematopoietic cells. Clearly, the elucidation of the biochemical function of the Pdcd4 protein will be an important goal for future work and might help to further understand the role of this interesting novel Myb target gene.
Materials and methods
Cell-lines
The chicken cell lines BM2 (AMV-transformed myeloblasts), HD11 (MC29-transformed macrophages) and HD3 (AEVtransformed erythroblasts) have been described (Klempnauer et al., 1983; Burk et al., 1993) . 10.4 is a derivative of the HD11 cell line expressing a v-Myb/ER fusion protein (Burk and Klempnauer, 1991) . QT6 is a line of quail ®broblasts derived from a methylcholanthrene-induced ®brosarcoma (Moscovici et al., 1977) . QT6 cells were grown in Iscove's modi®ed DMEM supplemented with 8% fetal calf serum and 2% chicken serum. An E26 transformed myeloblast cell line was obtained from T Graf and was grown in the same medium as QT6 cells. SC2L (Chen et al., 1983) and DT40 (Buerstedde et al., 1990) are chicken B-cell lines and MSB1 (Akiyama and Kato, 1974 ) is a chicken T-cell line; they were grown in RMPI1640 medium supplemented with 8% fetal calf serum, 2% chicken serum and 32 mM b-mercaptoethanol. Chicken embryo ®broblasts were obtained from Flow Laboratories and were grown in the same medium as QT6 cells. The MEP cell-lines HD50 (Kulessa et al., 1995) and HD57 (Metz and Graf, 1991) and primary E26-and AMVtransformed myeloblasts were obtained from T Graf and were used directly for the preparation of RNA. Subclones of the HD11 cell line expressing the AMV version of v-Myb (clones 26.2, 26.3) or the E26 version of v-Myb (clones 27.5, 27.10), and control clones expressing no Myb (clones 28.3, 28.4) have been described before .
Differential display
Dierential display was performed as described by Liang and Pardee (1992) with some modi®cations: Total RNA was prepared from 10.4 cells grown with or without 2 mM bestradiol for 24 h and digested with DNAse as described (Liang et al., 1993) to remove contaminating genomic DNA. 2.5 mg of total RNA was reverse transcribed with 200 U MMLV-RT (Superscript, Gibco ± BRL) in the presence of 2.5 mM oligo(dT)-based primer and 500 mM dNTP at 508C in a volume of 20 ml. After heat inactivation of the enzyme at 958C (5 min) the reaction was diluted with 10 mM Tris-HCl, pH 7.5, 1 mM EDTA to 250 ml. Two ml of the diluted cDNA was then used for PCR (2 mM dNTP, 2 mCi 33 P-dATP, 1 U native Taq polymerase (Perkin-Elmer), 2 mM oligo(dT)-based primer, 1 mM random decamer primer in buer containing 50 mM KCl, 10 mM Tris-HCl, pH 8.4, 1 mM MgCl 2 0.01% gelatin). Cycling parameters were as follows: 2 min at 948C were followed by 36 cycles of 948C (30 s), 408C (1 min), 728C (30 s), followed by ®nal 5 min at 728C. The ampli®ed DNA was separated on a 6% sequencing gel. Recovery and reampli®cation of fragments of interest was performed as described (Liang et al., 1993) . The reampli®ed fragments were separated on agarose gels, the DNA extracted and cloned into pCR-Script vector (Stratagene). Sequencing was carried out using the T7 sequencing kit (Pharmacia). The i11/6 dierential display fragment was obtained with the oligo(dT)-based primer T 12 GA and the random primer TGGATTGGTC.
Isolation of i11/6 cDNA clones A lgt11 cDNA library of the BM2 cell line was screened under high stringency conditions with probes derived from the i11/6 dierential display fragment. EcoRI insert fragments of positive phages were subcloned into pbluescript vector (Stratagene), sequenced using the T7 sequencing kit (Pharmacia) and used to deduce the complete open reading frame of the i11/6 gene (EMBL/GenBank/DDBJ accession number AF321288).
Expression vectors
An expression vector for HA-tagged i11/6 protein was generated by amplifying the i11/6 coding region by PCR, using the forward primer 5'-GTGATATCCATGGAAATA-GAAAAGCAGCAT-3' and the reverse primer 5'-CACTCG-AGCT CATCTAGCATAATCTGG AACATCATATGGAT-ACATAGAT CTGTAGCT TTCTGGT TTAAGCCGGCCT-C-3'. The HA-tag is encoded by the reverse primer. The PCR product was cloned into the vector pCR2.1-TOPO (Invitrogen), veri®ed by nucleotide sequencing, and subcloned into pcDNA3 (Invitrogen) by using¯anking BstXI restriction sites.
Northern blotting
Preparation of polyadenylated RNA and Northern blotting were performed as described (Burk et al., 1993) . Total RNA was prepared according to Chomczynski and Sacchi (1987) or by using the`Perfect RNA, Eucaryotic, Mini' kit (Eppendorf) according to the manufacturors instructions. To detect i11/6 RNA, the dierential display fragment or an approximately 860 bp BglII fragment (encompassing part of the i11/6 coding and 3' untranslated region) was used as a probe. A GAPDHspeci®c probe was used to standardize RNA blots.
DNA fragmentation analysis
DT40 cells were UV irradiated in an open tissue culture dish for 30 s with approximately 100 microwatts per cm 2 using the UV-light source (254 nm) of a standard tissue culture hood. Alternatively, cells were grown in the presence of 10 mM Cytosine-b-D-Arabinofuranoside (Ara-C). Cells were cultured further and after dierent time periods samples were lysed in buer containing 10 mM Tris-HCl, pH 7.5; 10 mM EDTA; 150 mM NaCl; 1% (v/v) Triton X-100 and 0.1 mg/ml freshly added Proteinase K, followed by incubation for 20 min at room temperature. Subsequently, 0.1 mg/ml RNase was added and the samples were incubated at 508C for 30 min. High molecular weight DNA was sheared and size fractionated by electrophoresis in a 2% agarose gel and visualized by staining with ethidium bromide.
DNA transfections and immunofluorescence analysis
DNA transfection was performed as described previously using the QT6 cell line (Burk et al., 1993) . Twenty-four hours after transfection total cellular protein was fractionated by SDS-polyacrylamide gel electrophoresis and analysed by Western blotting with the HA-specifc monoclonal antibody HA.11 (BAbCO). For immuno¯uorescence analysis, transfected cells were grown on glass coverslips coated with poly-D-lysine. Cells were ®xed with 3% paraformaldehyde in phosphate buered saline for 15 min, followed by incubation with 50 mM NH 4 Cl at room temperature for 10 min. The cells were then permeabilized with 0.2% Triton X-100 at room temperature for 5 min and immunostained using the HA-speci®c monoclonal antibody HA.11 (BAbCO) and rhodamine-coupled anti mouse antibodies (Roche Diagnostics).
